Lv1
68 积分 2023-07-25 加入
Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling
9天前
已完结
Pathway-selective 5-HT1AR agonist as a rapid antidepressant strategy
2个月前
已完结
Targeting protein disorder: the next hurdle in drug discovery
3个月前
已完结
Pharmacokinetic, pharmacodynamic and subjective and effects of the novel 5-HT2A receptor agonist GM-2505 in healthy volunteers
5个月前
已关闭
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
5个月前
已完结
New epilepsy therapies in development
5个月前
已完结
Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy
5个月前
已完结
22. GM-2505 has Rapid Onset Antidepressant Activity and Causes Dose-Dependent Changes in qEEG With Increasing 5-HT2A Receptor Occupancy
6个月前
已完结
The polypharmacology of psychedelics reveals multiple targets for potential therapeutics
6个月前
已完结
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder
6个月前
已完结
皖公网安备34019202002308
